An F.D.A. analysis suggests that J.&J. has not presented robust evidence for booster shots. by BY CARL ZIMMER AND NOAH WEILAND

The agency said also said that it didn’t have enough time to independently review much of the raw data from the company’s trials.

Published: October 13, 2021 at 05:47PM

from NYT Health